Muscle-specific expression of LARGE restores neuromuscular transmission deficits in dystrophic LARGEmyd mice

Human Molecular Genetics

Volumn 22, Issue 4, 2013, Pages 757-768

  Gumerson, Jessica D ^a   Davis, Carol S ^a   Kabaeva, Zhyldyz T ^a   Hayes, John M ^a   Brooks, Susan V ^a,b   Michele, Daniel E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; DYSTROGLYCAN; GLYCOSYLTRANSFERASE; LIKE ACETYLGLUCOSAMINYLTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CREATINE KINASE BLOOD LEVEL; ENZYME ACTIVITY; MOUSE; MUSCLE CONTRACTILITY; MUSCLE DEVELOPMENT; MUSCULAR DYSTROPHY; NERVE CONDUCTION; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STERNOCLEIDOMASTOID MUSCLE;

ANIMALS; DYSTROGLYCANS; GLYCOSYLATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR SKILLS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MYOCARDIUM; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEUROMUSCULAR JUNCTION; ORGAN SPECIFICITY; PROTEIN PROCESSING, POST-TRANSLATIONAL; SYNAPTIC TRANSMISSION;

EID: 84873036427     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds483     Document Type: Article

References (51)

1. Godfrey, C., Foley, A.R., Clement, E. and Muntoni, F. (2011) Dystroglycanopathies: coming into focus. Curr. Opin. Genet. Dev., 21, 278-285.
2. Martin, P.T. (2005) The dystroglycanopathies: the new disorders of O-linked glycosylation. Semin. Pediatr. Neurol., 12, 152-158.
3. Ibraghimov-Beskrovnaya, O., Ervasti, J.M., Leveille, C.J., Slaughter, C.A., Sernett, S.W. and Campbell, K.P. (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature, 355, 696-702.
4. Smalheiser, N.R. and Schwartz, N.B. (1987) Cranin: a laminin-binding protein of cell membranes. Proc. Natl Acad. Sci. USA, 84, 6457-6461.
5. Ervasti, J.M. and Campbell, K.P. (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol., 122, 809-823.
6. Gee, S.H., Montanaro, F., Lindenbaum, M.H. and Carbonetto, S. (1994) Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell, 77, 675-686.
7. Sugita, S., Saito, F., Tang, J., Satz, J., Campbell, K. and Sudhof, T.C. (2001) A stoichiometric complex of neurexins and dystroglycan in brain. J. Cell Biol., 154, 435-445.
8. Michele, D.E. and Campbell, K.P. (2003) Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J. Biol. Chem., 278, 15457-15460.
9. Michele, D.E., Barresi, R., Kanagawa, M., Saito, F., Cohn, R.D., Satz, J.S., Dollar, J., Nishino, I., Kelley, R.I., Somer, H. et al. (2002) Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature, 418, 417-422.
10. Muntoni, F., Brockington, M., Torelli, S. and Brown, S.C. (2004) Defective glycosylation in congenital muscular dystrophies. Curr. Opin. Neurol., 17, 205-209.
11. Han, R., Kanagawa, M., Yoshida-Moriguchi, T., Rader, E.P., Ng, R.A., Michele, D.E., Muirhead, D.E., Kunz, S., Moore, S.A., Iannaccone, S.T. et al. (2009) Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan. Proc. Natl Acad. Sci. USA, 106, 12573-12579.
12. Williamson, R.A., Henry, M.D., Daniels, K.J., Hrstka, R.F., Lee, J.C., Sunada, Y., Ibraghimov-Beskrovnaya, O. and Campbell, K.P. (1997) Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum. Mol. Genet., 6, 831-841.
13. Matsumura, K., Yamada, H., Shimizu, T. and Campbell, K.P. (1993) Differential expression of dystrophin, utrophin and dystrophin-associated proteins in peripheral nerve. FEBS Lett., 334, 281-285.
14. Saito, F., Masaki, T., Kamakura, K., Anderson, L.V., Fujita, S., Fukuta-Ohi, H., Sunada, Y., Shimizu, T. and Matsumura, K. (1999) Characterization of the transmembrane molecular architecture of the dystroglycan complex in Schwann cells. J. Biol. Chem., 274, 8240-8246.
15. Yamada, H., Shimizu, T., Tanaka, T., Campbell, K.P. and Matsumura, K. (1994) Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. FEBS Lett., 352, 49-53.
16. Yamada, H., Denzer, A.J., Hori, H., Tanaka, T., Anderson, L.V., Fujita, S., Fukuta-Ohi, H., Shimizu, T., Ruegg, M.A. and Matsumura, K. (1996) Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane. J. Biol. Chem., 271, 23418-23423.
17. Saito, F., Moore, S.A., Barresi, R., Henry, M.D., Messing, A., Ross-Barta, S.E., Cohn, R.D., Williamson, R.A., Sluka, K.A., Sherman, D.L. et al. (2003) Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron, 38, 747-758.
18. Cote, P.D., Moukhles, H., Lindenbaum, M. and Carbonetto, S. (1999) Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nat. Genet., 23, 338-342.
19. Gesemann, M., Cavalli, V., Denzer, A.J., Brancaccio, A., Schumacher, B. and Ruegg, M.A. (1996) Alternative splicing of agrin alters its binding to heparin, dystroglycan, and the putative agrin receptor. Neuron, 16, 755-767.
20. Hopf, C. and Hoch, W. (1996) Agrin binding to alpha-dystroglycan. Domains of agrin necessary to induce acetylcholine receptor clustering are overlapping but not identical to the alpha-dystroglycan-binding region. J. Biol. Chem., 271, 5231-5236.
21. Jacobson, C., Cote, P.D., Rossi, S.G., Rotundo, R.L. and Carbonetto, S. (2001) The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane. J. Cell Biol., 152, 435-450.
22. Grady, R.M., Zhou, H., Cunningham, J.M., Henry, M.D., Campbell, K.P. and Sanes, J.R. (2000) Maturation and maintenance of the neuromuscular synapse: genetic evidence for roles of the dystrophin-glycoprotein complex. Neuron, 25, 279-293.
23. Grewal, P.K., Holzfeind, P.J., Bittner, R.E. and Hewitt, J.E. (2001) Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse. Nat. Genet., 28, 151-154.
24. Holzfeind, P.J., Grewal, P.K., Reitsamer, H.A., Kechvar, J., Lassmann, H., Hoeger, H., Hewitt, J.E. and Bittner, R.E. (2002) Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Large(myd) mouse defines a natural model for glycosylation-deficient muscle-eye-brain disorders. Hum. Mol. Genet., 11, 2673-2687.
25. Longman, C., Brockington, M., Torelli, S., Jimenez-Mallebrera, C., Kennedy, C., Khalil, N., Feng, L., Saran, R.K., Voit, T., Merlini, L. et al. (2003) Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum. Mol. Genet., 12, 2853-2861.
26. van Reeuwijk, J., Grewal, P.K., Salih, M.A., Beltran-Valero de Bernabe, D., McLaughlan, J.M., Michielse, C.B., Herrmann, R., Hewitt, J.E., Steinbrecher, A., Seidahmed, M.Z. et al. (2007) Intragenic deletion in the LARGE gene causes Walker-Warburg syndrome. Hum. Genet., 121, 685-690.
27. Levedakou, E.N., Chen, X.J., Soliven, B. and Popko, B. (2005) Disruption of the mouse Large gene in the enr and myd mutants results in nerve, muscle, and neuromuscular junction defects. Mol. Cell. Neurosci., 28, 757-769.
28. Herbst, R., Iskratsch, T., Unger, E. and Bittner, R.E. (2009) Aberrant development of neuromuscular junctions in glycosylation-defective Large(myd) mice. Neuromuscul. Disord., 19, 366-378.
29. Barresi, R., Michele, D.E., Kanagawa, M., Harper, H.A., Dovico, S.A., Satz, J.S., Moore, S.A., Zhang, W., Schachter, H., Dumanski, J.P. et al. (2004) LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nat. Med., 10, 696-703.
30. Gumerson, J.D., Kabaeva, Z.T., Davis, C.S., Faulkner, J.A. and Michele, D.E. (2010) Soleus muscle in glycosylation-deficient muscular dystrophy is protected from contraction-induced injury. Am. J. Physiol. Cell Physiol., 299, C1430-C1440.
31. Kelly, D., Chancellor, K., Milatovich, A., Francke, U., Suzuki, K. and Popko, B. (1994) Autosomal recessive neuromuscular disorder in a transgenic line of mice. J. Neurosci., 14, 198-207.
32. Clement, E., Mercuri, E., Godfrey, C., Smith, J., Robb, S., Kinali, M., Straub, V., Bushby, K., Manzur, A., Talim, B. et al. (2008) Brain involvement in muscular dystrophies with defective dystroglycan glycosylation. Ann. Neurol., 64, 573-582.
33. van Reeuwijk, J., Janssen, M., van den Elzen, C., Beltran-Valero de Bernabe, D., Sabatelli, P., Merlini, L., Boon, M., Scheffer, H., Brockington, M., Muntoni, F. et al. (2005) POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome. J. Med. Genet., 42, 907-912.
34. Beltran-Valero de Bernabe, D., Currier, S., Steinbrecher, A., Celli, J., van Beusekom, E., van der Zwaag, B., Kayserili, H., Merlini, L., Chitayat, D., Dobyns, W.B. et al. (2002) Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am. J. Hum. Genet., 71, 1033-1043.
35. Kabaeva, Z., Meekhof, K.E. and Michele, D.E. (2011) Sarcolemma instability during mechanical activity in Largemyd cardiac myocytes with loss of dystroglycan extracellular matrix receptor function. Hum. Mol. Genet., 20, 3346-3355.
36. Cartaud, A., Coutant, S., Petrucci, T.C. and Cartaud, J. (1998) Evidence for in situ and in vitro association between beta-dystroglycan and the subsynaptic 43K rapsyn protein. Consequence for acetylcholine receptor clustering at the synapse. J. Biol. Chem., 273, 11321-11326.
37. Bradley, W.G. and Jenkison, M. (1975) Neural abnormalities in the dystrophic mouse. J. Neurol. Sci., 25, 249-255.
38. Wallquist, W., Plantman, S., Thams, S., Thyboll, J., Kortesmaa, J., Lannergren, J., Domogatskaya, A., Ogren, S.O., Risling, M., Hammarberg, H. et al. (2005) Impeded interaction between Schwann cells and axons in the absence of laminin alpha4. J. Neurosci., 25, 3692-3700.
39. Yang, D., Bierman, J., Tarumi, Y.S., Zhong, Y.P., Rangwala, R., Proctor, T.M., Miyagoe-Suzuki, Y., Takeda, S., Miner, J.H., Sherman, L.S. et al. (2005) Coordinate control of axon defasciculation and myelination by laminin-2 and -8. J. Cell Biol., 168, 655-666.
40. Qu, Q. and Smith, F.I. (2005) Neuronal migration defects in cerebellum of the Largemyd mouse are associated with disruptions in Bergmann glia organization and delayed migration of granule neurons. Cerebellum, 4, 261-270.
41. Zweifel, L.S., Kuruvilla, R. and Ginty, D.D. (2005) Functions and mechanisms of retrograde neurotrophin signalling. Nat. Rev. Neurosci., 6, 615-625.
42. Maisonpierre, P.C., Belluscio, L., Friedman, B., Alderson, R.F., Wiegand, S.J., Furth, M.E., Lindsay, R.M. and Yancopoulos, G.D. (1990) NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron, 5, 501-509.
43. Koliatsos, V.E., Clatterbuck, R.E., Winslow, J.W., Cayouette, M.H. and Price, D.L. (1993) Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo. Neuron, 10, 359-367.
44. Henderson, C.E., Phillips, H.S., Pollock, R.A., Davies, A.M., Lemeulle, C., Armanini, M., Simmons, L., Moffet, B., Vandlen, R.A., Simpson, L.C. et al. (1994) GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science, 266, 1062-1064.
45. Funakoshi, H., Belluardo, N., Arenas, E., Yamamoto, Y., Casabona, A., Persson, H. and Ibanez, C.F. (1995) Muscle-derived neurotrophin-4 as an activity-dependent trophic signal for adult motor neurons. Science, 268, 1495-1499.
46. Nagano, M. and Suzuki, H. (2003) Quantitative analyses of expression of GDNF and neurotrophins during postnatal development in rat skeletal muscles. Neurosci. Res., 45, 391-399.
47. Henderson, C.E., Camu, W., Mettling, C., Gouin, A., Poulsen, K., Karihaloo, M., Rullamas, J., Evans, T., McMahon, S.B., Armanini, M.P. et al. (1993) Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature, 363, 266-270.
48. Nico, B., Mangieri, D., De Luca, A., Corsi, P., Benagiano, V., Tamma, R., Annese, T., Longo, V., Crivellato, E. and Ribatti, D. (2009) Nerve growth factor and its receptors TrkA and p75 are upregulated in the brain of mdx dystrophic mouse. Neuroscience, 161, 1057-1066.
49. Toti, P., Villanova, M., Vatti, R., Schuerfeld, K., Stumpo, M., Barbagli, L., Malandrini, A. and Costantini, M. (2003) Nerve growth factor expression in human dystrophic muscles. Muscle Nerve, 27, 370-373.
50. Schmidt, N., Akaaboune, M., Gajendran, N., Martinez-Pena, Y.V.I., Wakefield, S., Thurnheer, R. and Brenner, H.R. (2011) Neuregulin/ErbB regulate neuromuscular junction development by phosphorylation of alpha-dystrobrevin. J. Cell Biol., 195, 1171-1184.
51. Guyenet, S.J., Furrer, S.A., Damian, V.M., Baughan, T.D., La Spada, A.R. and Garden, G.A. (2010) A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia. J. Vis. Exp, 39, 000.